Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. The company offers products for treatment areas, such as skin rejuvenation, lifting/tightening, pigmentation treatments, fat reduction, acne, tattoo removal, and scars and striae distensae under the ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel brands. It provides its products through a network of distributors. The company was founded in 2001 and is based in Seoul, South Korea. As of July 22, 2024, Jeisys Medical Inc. operates as a subsidiary of Syracuse Subco, Inc..
Show more...
CEO
Won-Ju Lee
従業員
275
国
韓国
ISIN
KR7287410005
上場銘柄
0 Comments
意見をシェア
FAQ
Yuanta 3 Special Purpose Acquisition.の株価は今日いくらですか?▼